Fed. Circ. OKs Ruling Barring Generic Lyrica Until 2018
Pfizer Inc. on Thursday won a ruling from the Federal Circuit upholding a lower court's decision blocking a slew of generic-drug makers, including Teva Pharmaceuticals USA Inc. and Actavis Inc., from...To view the full article, register now.
Already a subscriber? Click here to view full article